Efficacy and Safety of AK002 in Adult Patients With Active Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis: Primary Results From a Randomized, Double-Blind Placebo-Controlled Phase 2 Trial (ENIGMA Study) (late-breaking abstract)